A detailed history of Gabelli & CO Investment Advisers, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Gabelli & CO Investment Advisers, Inc. holds 1,125 shares of BDX stock, worth $256,140. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,125
Previous 1,125 -0.0%
Holding current value
$256,140
Previous $262,000 3.44%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$225.07 - $246.17 $253,203 - $276,941
1,125 New
1,125 $262,000
Q1 2022

May 13, 2022

SELL
$243.64 - $270.48 $241,203 - $267,775
-990 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$232.09 - $256.88 $2,320 - $2,568
10 Added 1.02%
990 $241,000
Q4 2020

Feb 05, 2021

BUY
$221.92 - $245.94 $6,657 - $7,378
30 Added 3.16%
980 $245,000
Q2 2020

Aug 13, 2020

BUY
$219.9 - $263.41 $208,905 - $250,239
950 New
950 $227,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Gabelli & CO Investment Advisers, Inc. Portfolio

Follow Gabelli & CO Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.